tanshinone ii a has been researched along with parthenolide, (1ar-(1ar*,4e,7as*,10as*,10br*))-isomer in 1 studies
Studies (tanshinone ii a) | Trials (tanshinone ii a) | Recent Studies (post-2010) (tanshinone ii a) | Studies (parthenolide, (1ar-(1ar*,4e,7as*,10as*,10br*))-isomer) | Trials (parthenolide, (1ar-(1ar*,4e,7as*,10as*,10br*))-isomer) | Recent Studies (post-2010) (parthenolide, (1ar-(1ar*,4e,7as*,10as*,10br*))-isomer) |
---|---|---|---|---|---|
61 | 0 | 41 | 16 | 0 | 14 |
Protein | Taxonomy | tanshinone ii a (IC50) | parthenolide, (1ar-(1ar*,4e,7as*,10as*,10br*))-isomer (IC50) |
---|---|---|---|
Nuclear factor NF-kappa-B p105 subunit | Homo sapiens (human) | 0.467 | |
Nuclear factor NF-kappa-B p100 subunit | Homo sapiens (human) | 0.467 | |
Transcription factor p65 | Homo sapiens (human) | 0.467 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abdeen, S; Chapman, E; Chitre, S; Hoang, QQ; Johnson, SM; Park, Y; Ray, AM; Salim, N; Sivinski, J; Stevens, M; Washburn, A | 1 |
1 other study(ies) available for tanshinone ii a and parthenolide, (1ar-(1ar*,4e,7as*,10as*,10br*))-isomer
Article | Year |
---|---|
HSP60/10 chaperonin systems are inhibited by a variety of approved drugs, natural products, and known bioactive molecules.
Topics: Biological Products; Chaperonin 10; Chaperonin 60; Escherichia coli; Humans; Inhibitory Concentration 50; Protein Folding; Rafoxanide; Salicylanilides; Suramin | 2019 |